Extended STEER Results: Continued Motor Gains With IT Onasemnogene Abeparvovec in SMA STEER trial 64-week data suggest intrathecal OAV101 provides sustained and progressive motor function improvement in children with SMA.

Extended 64-week data from the #STEER trial suggest a single dose of #OAV101 IT provides sustained, progressive motor function improvement in children and adolescents with #SMA. Data to be presented at the 2026 @mda.org #MDAConference

Read more: https://bit.ly/3MXxlNJ

#RareDisease #MedSky

See OAV101 gene therapy safety results—read more here: https://bit.ly/454xpSl

#SMA #GeneTherapy #OAV101 #SMANews #Bionews